Elisabetta Metafuni

27PUBLICATIONS
149CO-AUTHORS
Predictive and prognostic markersTransplantation immunologyHaematologyEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 12, 2026
TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-Analysis.

|Oct 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.

Patryk Sobieralski, Tomasz Czerw, Luuk Gras

|Aug 11, 2025
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience.

Bruno Fattizzo, Giacinto Luca Pedone, Elisabetta Metafuni

|Feb 22, 2025
Real-world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study.

Elisabetta Metafuni, Filippo Achille Brioschi, Andrea Patriarca

|Nov 20, 2024
The role of daratumumab in complications post-allogeneic hematopoietic stem cell transplantation: a single-center prospective study on PRCA and AIHA.

S Giammarco, M A Limongiello, Luca Di Marino

|Jul 27, 2024
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.

Alessandra Vergori, Giulia Matusali, Eleonora Cimini

Pageof 5

Frequent Collaborators

16 joint publications

Patrizia Chiusolo

10 joint publications

Simona Sica

10 joint publications

Federica Sora

8 joint publications

Sabrina Giammarco